CN Patent

CN104710345B — 用于制备4‑（2‑（4‑甲基苯基硫基））苯基哌啶的化合物、其制备方法及应用

Assigned to Nhwa Pharmaceutical Corp · Expires 2017-09-05 · 9y expired

What this patent protects

本发明公开了用于制备4‑（2‐（4‐甲基苯基硫基））苯基哌啶的化合物、其制备方法及应用。本发明提供了两种制备4‑（2‐（4‐甲基苯基巯基））苯基哌啶的中间体：3‑（2‐（4‐甲基苯基巯基））苯基戊二酸和4‑（2‐（4‐甲基苯基巯基））苯基哌啶‐2，6‐二酮及其制备与应用。该方法收率高，操作安全、方便，对环境污染小且利于工业化生产。

USPTO Abstract

本发明公开了用于制备4‑（2‐（4‐甲基苯基硫基））苯基哌啶的化合物、其制备方法及应用。本发明提供了两种制备4‑（2‐（4‐甲基苯基巯基））苯基哌啶的中间体：3‑（2‐（4‐甲基苯基巯基））苯基戊二酸和4‑（2‐（4‐甲基苯基巯基））苯基哌啶‐2，6‐二酮及其制备与应用。该方法收率高，操作安全、方便，对环境污染小且利于工业化生产。

Drugs covered by this patent

Patent Metadata

Patent number
CN104710345B
Jurisdiction
CN
Classification
—
Expires
2017-09-05
Drug substance claim
No
Drug product claim
No
Assignee
Nhwa Pharmaceutical Corp
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.